Leukaemia UK

The recipient of our 2025 Patient Care Pioneer Award: Dr Sarah Stapleton 🏆

Dr Stapleton will look at the psychological support that leukaemia patients might need, and develop a framework to help guide healthcare professionals.

www.leukaemiauk.org.uk/research-and...

An image of a T-cell, a type of lymphocyte which plays a vital role in the body’s immune system. The text on the image reads, ‘Major study uncovers new subtype of T-cell ALL, which can be detected using routine tests at point of diagnosis’.

Major breakthrough for T-ALL! Researchers have identified a previously unknown subtype, which can be detected using routine tests. 👏

This means clinicians could soon pinpoint high-risk cases at diagnosis & personalise treatment for children with T-ALL.

bioengineer.org/breakthrough...

Nearly all NHS hospitals are missing cancer targets - is yours one of them? Experts say patients are being harmed by cancer diagnosis and treatment delays.

This is deeply concerning. Early diagnosis is crucial for successful treatment in all cancers, including leukaemia, which is why we’re calling on the Government to commit to urgently tackling delays in early diagnosis in their upcoming National Cancer Plan.
www.bbc.co.uk/news/article...

A scientist working in a lab. He is wearing a white lab coat and using a microscope and test tubes. The text on the image reads, ‘Have your say’ alongside an icon of a person holding a tablet and filling out an online survey.

Last chance to share your views! How do you want to hear about the impact of your incredible support?

We want to make sure that you’re the first to know about the life-saving research we’re funding, all thanks to you. 🧡

Have your say: https://survey.alchemer.eu/s3/90953656/a60c0b257002

The common drug that can reduce side effects for cancer patients The common cholesterol-lowering medication protects patients’ mental skills used to plan, organise and manage emotions

Promising news! Researchers have found that statins, a cholesterol-lowering drug, could help to tackle “chemo brain” - a debilitating cognitive side effect for many cancer patients. 🤞

www.independent.co.uk/news/health/...

A graphic with an icon of a person holding a tablet in their hands and filling out an online survey. The text reads, ‘Share your views. How do you want to hear about the impact of your support?’

We want to hear from you - our fantastic supporters!

How can we keep you informed about the impact of your incredible support, and how it’s helping us to fund life-changing leukaemia research?

Fill in our short survey by midnight on Mon 10th Nov: survey.alchemer.eu/s3/90953656/...

A decade of progress and impact - Leukaemia UK This October marks ten years since Leukaemia UK launched its John Goldman Fellowship (JGF) programme. In this blog, and the next, we’ll explore its impact and successes.

A decade of bold ideas, brilliant minds & real impact. 💡

Our John Goldman Fellowships are driving progress in leukaemia research, from identifying new drug targets to repurposing existing medicines.

Read more: www.leukaemiauk.org.uk/stories/a-de...

We’re continuing to fund incredible research and talented scientists who are working hard to find kinder, more effective treatments to stop leukaemia devastating lives. But none of this would be possible without your support. 🧡

Here are a few words from our researchers… 🎥

Enhanced Resistance Mapping of CML ABL1 Variants Recent advancements in the realm of precision medicine have brought to light the complexities surrounding the treatment of chronic myeloid leukaemia (CML), particularly when it comes to understanding

Researchers have used gene-editing tools to map mutations in the ABL1 kinase domain - a critical component driving CML - and identify which of these mutations are resistant to certain drugs, opening the door to more personalised treatment options. 👏
scienmag.com/enhanced-res...

Clive Jones, MP for Wokingham, speaking in Westminster Hall. He is wearing a suit with a yellow tie and pocket square, and holding papers in his hands.

Thank you @clivejonesmp.bsky.social for leading today's Westminster Hall debate and raising the issues faced by leukaemia patients.

Our thanks also to @drscottarthurmp.bsky.social for echoing our call to ensure the upcoming 10-Year Workforce Plan enables and supports the National Cancer Plan.

An image of red blood cells in the bloodstream. The text on top of the image reads, ‘New study unveils potential dual drug approach for AML using existing multiple myeloma treatment’.

Exciting news! Researchers have now uncovered why proteasome inhibitors, a class of drugs that work well in multiple myeloma, aren’t as effective in AML patients - and how to change this. 👏

Read more: www.technologynetworks.com/tn/news/dual...

Thank you Gavin Williamson MP for raising Ruth’s case in Parliament and asking the Government what steps are being taken to support patients with AML.

We welcome @ashleydaltonmp.bsky.social's recommitment to improving AML survival, something we are calling for in the upcoming National Cancer Plan.

A lecture theatre filled with people. One person is sitting at the front behind a desk, while another person is stood at a lectern speaking into a microphone. Two screens are visible behind them, with text which reads, ‘AML in Spatial Context: Mapping Tumour-Microenvironment Relationships. Simona Valletta, PhD’.

We’re thrilled to have co-supported Molecular Haemopoiesis 2025, bringing together leading researchers exploring blood cell development. 🩸

It was great to see some of our past & present John Goldman Fellows deliver fascinating talks, and see such impactful science in action! 🔬

Dr Gillian Horne - Building better diagnostic tools to treat Ph+ ALL: a challenging leukaemia subtype

We’re delighted to announce our second John Goldman Fellow for 2025 and this year’s Olive Boles Innovation Award winner - Dr Gillian Horne from @uofglasgow.bsky.social 🔬

Her research focuses on building better diagnostic tools to treat Ph+ ALL.

Read more: www.leukaemiauk.org.uk/research-and...

An orange graphic with the text, ‘Diagnose earlier. Diagnose better. Save lives.' in bullet points using the tick symbol. At the bottom is the Leukaemia UK logo and ‘Count Us In’ campaign icon.

⚠️ Last chance to make your voice heard and tell the Government to stop avoidable delays in leukaemia diagnosis.

Join us in demanding better for leukaemia patients ➡️ action.leukaemiauk.org.uk/count-us-in

#CountUsIn

So humbled to receive the John Goldman Fellowship from @leukaemiauk.bsky.social to identify new metabolic vulnerabilities of B-ALL for future gentler and more targeted therapies. @edinuni-irr.bsky.social @cmvm-edinburghuni.bsky.social @edinburgh-uni.bsky.social

📢 We’re funding two new groundbreaking studies, aimed at developing kinder, more effective treatments for acute lymphoblastic leukaemia (ALL).

Meet @comazzettolab.bsky.social from @edinuni-irr.bsky.social - one of our two new John Goldman Fellows for 2025.

www.leukaemiauk.org.uk/research-and...

An orange graphic with an image of Tracey, one of Leukaemia UK’s Community Champions. A quote from Tracey reads, ‘I saw my GP several times over months with symptoms including bone pain, exhaustion, bruising and mouth ulcers. I wasn’t offered a full blood count test and was told it was rheumatoid arthritis, but the medication didn’t help. It wasn’t until I fainted and ended up in A&E four months later that I was finally diagnosed with AML. Tracey Palmer-Hole, AML survivor.'

Unfortunately, Tracey’s story isn’t uncommon. A shocking 1 in 4 leukaemia patients experience avoidable delays in their diagnosis. It’s time to change this. 💪

Join us in calling for the Government to commit to taking action ➡️ action.leukaemiauk.org.uk/count-us-in

#CountUsIn

An orange graphic with a title at the top which reads, ‘10 years of our John Goldman Fellowships’ followed by four statistics: £6 million of funding, 46 Fellowships awarded, 286 papers published, 27% more global partnerships.

This month, we’re celebrating a very special milestone: 10 years of our John Goldman Fellowship funding programme. ✨

Over the past decade, our Fellowships have empowered early-career researchers to pursue ideas that push the boundaries of science.

🔗: www.leukaemiauk.org.uk/stories/rese...

Four people are stood at the Leukaemia UK stand at the Labour Party Conference, including Leukaemia UK CEO, Fiona Hazell, and Anas Sarwar MSP. Anas is holding a sign which reads, ‘I demand earlier, better diagnosis’.

You can still help to ensure change happens, by writing to the Government and highlighting our findings ➡️ action.leukaemiauk.org.uk/count-us-in

#LabourPartyConference (2/2)

Wes Streeting, the Secretary of State for Health and Social Care, is stood with members of Leukaemia UK’s Policy & Advocacy team at the Labour Party Conference. He is holding a sign which reads, ‘Let’s stop avoidable delays in diagnosis'.

A fantastic few days at the #Lab25 conference, speaking with MPs and policymakers, including @rthonwesstreeting.bsky.social, about our #CountUsIn campaign and the need for the upcoming National Cancer Plan to stop avoidable delays in leukaemia diagnosis. (1/2)

Thanks @tobyperkinsmp.bsky.social for taking time at #Lab25 to meet us. We discussed the importance of ensuring that earlier leukaemia diagnosis is prioritised across the NHS.

Really valuable conversation with @samcarling.bsky.social at #Lab25 about ending avoidable delays in leukaemia diagnosis. Thank you for supporting our Count Us In campaign.

It was a pleasure to meet @julietcampbellmp.bsky.social at #Lab25 and share how our Count Us In campaign is calling for earlier leukaemia diagnosis to be a priority in the new National Cancer Plan

Important conversation with @sarahowen.org.uk MP at #Lab25 about the need for urgent full blood counts to help diagnose (or rule out) leukaemia earlier. Thank you for your support.

Thank you @danfrancis02.bsky.social for taking the time to hear about the realities of leukaemia diagnostic delays. We look forward to your support in ensuring the National Cancer Plan drives change.

Great to speak with @afzalkhanmcr.bsky.social about the shocking delays too many leukaemia patients face. We need the National Cancer Plan to commit to faster diagnosis. #CountUsIn #Lab25

We were grateful to speak with Anas Sarwar at #Lab25 about the challenges in diagnosing leukaemia early and why addressing them must become a priority in Scotland

We were grateful to speak with Anas Sarwar at #Lab25 about the challenges in diagnosing leukaemia early and why addressing them must become a priority in Scotland

Thank you @imogenwalker.bsky.social for visiting our stand at #Lab25 and speaking with our Community Champion, Jonathan, about the importance of early diagnosis We’re calling on Government to make sure the National Cancer Plan delivers for people affected by leukaemia.